Quick Research
Filters Clear All
Any Time
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 25,274 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
A multifunctional hydrogel loaded with two nanoagents improves the pathological microenvironment associated with radiation combined with skin wounds (2023-02-01)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: Hacat Cells Line -
Targeted therapy for peri-prosthetic osteolysis using macrophage membrane-encapsulated human urine-derived stem cell extracellular vesicles (2023-02-10)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: RAW 264.7 Cells Line, Fetal Bovine Serum, Penicillin-Streptomycin Solution, 100× -
Hepar-on-a-sensor-platform with hybridization chain reaction amplification strategy to intuitively monitor the hepatoxicity of natural compounds (2023-02-16)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: Hep G2 Cells Line -
Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization (2023-03-15)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: 4T1 Cells Line -
A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation (2023-03-21)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: 4T1 Cells Line -
Intelligent gold nanoparticles for malignant tumor treatment via spontaneous copper manipulation and on-demand photothermal therapy based on copper induced click chemistry (2023-04-29)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: Human Umbilical Vein Endothelial cells -
Targeted long-term noninvasive treatment of choroidal neovascularization by biodegradable nanoparticles (2023-05-23)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: Rat Choroidal Vascular Endothelial cells, Human Umbilical Vein Endothelial cells -
A hyaluronic acid/silk fibroin/poly-dopamine-coated biomimetic hydrogel scaffold with incorporated neurotrophin-3 for spinal cord injury repair (2023-05-29)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: Neurotrophin-3 -
Aggregation-induced emission photosensitizer/bacteria biohybrids enhance Cerenkov radiation-induced photodynamic therapy by activating anti-tumor immunity for synergistic tumor treatment (2023-06-15)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: CT26.WT Cells Line -
PTT/ PDT-induced microbial apoptosis and wound healing depend on immune activation and macrophage phenotype transformation (2023-06-25)
Journal: Acta Biomaterialia (2023) IF: 9.7Products Cited: DC2.4 Cells Line, NCTC clone 929 [L cell, L-929] Cells Line
